PTX3 and metabolic syndrome: In prior studies, it was demonstrated that as a regulator of inflammatory response, PTX3 was involved in the progression of cardiovascular diseases, such as angiogenesis, atherosclerosis, extracellular matrix formation, and metabolic syndrome (Doni et al., 2019; Norata et al., 2010; Zhang et al., 2022).